Enveric Biosciences, Inc.
ENVB· Nasdaq
Filed Nov 13, 2014 · 10-Q · 44 days after period end · 0001079974-14-000780
| Metric | Q3 2014 | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|---|
| Net Income | -$3.18K | -$4.56K | -$4.87K | -$3.69K |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Enveric Biosciences, Inc. · CIK 890821 · Engraved from SEC EDGAR
ended Sep 30, 2014 · filed Nov 13, 2014 · 44 d after period end